RxDoctor Payments DataLook up a doctor →

Nicole Ciffone, NP

Acute Care · Tucson, AZNPI 1750369500

Payments from drug & device makers

$162,395in general payments, 2019–2025

Across 634 payments — averaging $256.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$97K
  • Regeneron Healthcare Solutions, Inc.$30K
  • Amgen$20K
  • Novartis$6K
  • AstraZeneca$4K
  • Amarin Pharma, Inc.$817
  • plus $4K from 25 others
$12,650in research payments, 2019–2025

Across 2 payments — averaging $6324.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$13K

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$162,395 in reported general payments places this provider in the 95th percentile of 482 acute care providers in Arizona.

See all acute care providers in Arizona

Medicare billing

Part B allowed, 2024
$145,338
Medicare patients
169
Services billed
9,470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →